To assess the effects of psychological interventions designed to improve adherence to disease-modifying therapies (DMTs) in adults with multiple sclerosis (MS) in terms of adherence. This will be considered in relation to levels of adherence in a comparison group.

Secondary objectives are to assess the impact of interventions on potential predictors of adherence such as motivation, self-efficacy beliefs and healthcare engagement to DMTs adherence.